Aditxt appoints Jeffrey M. Busch as interim CEO, replacing founder Amro Albanna
Aditxt Inc. named Jeffrey M. Busch, former CEO of NYSE-listed Global Medical REIT, as interim CEO effective May 31, 2026, while founder Amro Albanna resigned from all company positions. Busch will lead the company's commercialization strategy for its Ignite Proteomics precision oncology diagnostics platform while continuing as Ignite's CEO.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day